home       introduction       history       hospital       insurance       a.m.s.       contact us       donations
sickle cell centre          gallery          news & reports          training          jobs          new building          e-learning


 Sickle Cell Disease Centre

Sickle cell disease (SCD) is a significant problem among the tribals and the Chetty community of the Gudalur valley. Screening by the metabisulphite test and confirmation by hemoglobin electrophoresis was started at Gudalur Adivasi Hospital in 1998 with equipment donated by Dr.Ronald Nagel of Albert Einstein College of Medicine, New York City. The Centre was formalized in 2004 with the help of Mr.Hari Prabhakar of TIHF- (Tribal India health Foundation)  and ATMA-(American Tamil Medical Association). Since November 2007 the Tamil Nadu Government, through the Tamil Nadu Health Systems Project, has been funding the Centre for the detection and treatment of SCD.


The Centre provides comprehensive services for SCD to the resident indigenous and non-indigenous populations of the Nilgiris. Through a clinical and community-based approach, the Centre aims to develop a comprehensive model for SCD management, which may be applied to other settings to address the grave issue of SCD prevalence in many parts of rural India. Both pediatric and adult patients are seen.


The clinical services provided by the Centre are as follows:

* Hydroxyurea therapy for crisis-prone patients

* Immunization with 23-conjugate vaccine

* Vitamin supplementation and penicillin prophylaxis


The community services provided by the Centre include:

* Field screening camps

* Centre and field-based education and counseling



Illustration 1: Lab staff Pradeepa and Jayanthi, along with Erumad health animators, conducting a screening camp


Illustration 2: Immunizing a pediatric sickle cell patient with the pneumococcal vaccine


Illustration 3: Processing screening results in the laboratory


The research interests of the Centre include examining the epidemiology of SCD in the area, tracking patient outcomes, and exploring alternative plant-based therapies to sickle cell management.


The Centre is grateful for the continuing support from the following organizations:


* American Tamil Medical Association (www.atmaus.org)

* Tamil Nadu Health Systems Project, Govt. of Tamil Nadu (www.tnhsp.org)

* Tribal India Health Foundation (www.tihf.org)

* University of Illinois Sickle Cell Disease Centre (www.uicsicklecellcenter.org)


Operation Statistics (As of 12/25/08)

Patient Data

Number of Individuals Screened

6472

Number of Tribal Patients with Sickle Cell Disease

99

Number of Chetty Patients with Sickle Cell Disease

77

Number of Sickle Cell Patients Vaccinated with Pneumococcal Vaccine

51

Active Patients

176


Comprehensive Screening Data (Centre + Villages)

Total Individuals Screened

% Trait (HbAS)

% Disease (HbSS)

6472

14.71%

3.01%


Village Screening Data

Total Individuals Screened

% Trait (HbAS)

% Disease (HbSS)

2693

11.06%

.52%


Year Screening Data (November 2007-November 2008)

Number of Screening Camps

Number of Villages Covered

Total Number of Individuals Screened (Hospital and Field)

% Trait (HbAS)

% Disease (HbSS)

49

70

1894

8.8%

2.2%


Sickle Cell Inpatients Admissions

2003

2004

2005

2006

2007

2008

10

13

26

37

36

55


Additional reports, protocols, materials, and data sets may be found here: www.tihf.org/scd.htm